GCC Healthcare’s Talent Crunch
Talent and manpower are crucial elements in healthcare transformation, from trained clinicians to nurses, technical experts, and managers, but the GCC’s particularities create unique challenges in this regard. A full…
Patrick is the managing editor of PharmaBoardroom
Talent and manpower are crucial elements in healthcare transformation, from trained clinicians to nurses, technical experts, and managers, but the GCC’s particularities create unique challenges in this regard. A full…
SK Bioscience’s announcement that the first batch of its domestically developed COVID vaccine has been shipped may mark a significant milestone in South Korea’s journey towards greater vaccine self-sufficiency. …
AstraZeneca’s CEO Pascal Soriot warns that the new US legislation controlling drug prices would reduce innovators’ capacity to recover drug development investments and therefore discourage innovation, especially for drugs with smaller…
Takeda gets a first approval for QDENGA, its dengue vaccine, which has been given the green light by the Indonesian National Agency for Drug and Food Control, Badan Pengawas Obat…
After the prolonged underperformance of its generics division, Sandoz, Novartis has announced a spin off that will allow the company to focus on its core business and which is part…
Merck has agreed to front USD 150 million for Orna Therapeutics’ new investigational class of engineered circular RNA (oRNA) therapies in a collaboration agreement that will also provide the biotech…
While patient groups view the United States’ new Inflation Reduction Act as a positive move towards capping out-of-pocket drug costs for older Americans, the innovative pharma industry, after aggressively lobbying…
A selection of the latest stories from Chinese pharma, including Novartis’ bet that the country will become its second biggest market by 2024 through the introduction of 50 new drugs,…
Egypt’s largest pharmaceutical manufacturer by units, EIPICO, plans to diversify its production capacity by building the country’s first biological & biosimilar production plant. Not only that, the company is leading…
Pharma and biotech companies have demonstrated their commitment to diversity, equity and inclusion (DEI), particularly with respect to gender equality with more and more women in leadership positions. Insights from…
Some of the top pharma news coming out of South Africa including Afrigen’s partnership with US National Institutes of Health (NIH), BioNTech’s efforts to bring an mRNA start-to-finish vaccine manufacturing network…
After almost four years leading Sanofi’s second largest market, China, Pius S. Hornstein moves into a global role to focus on the company’s digital transformation. “In the last 8 years,…
See our Cookie Privacy Policy Here
